1. Home
  2. CPIX vs ADAP Comparison

CPIX vs ADAP Comparison

Compare CPIX & ADAP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CPIX
  • ADAP
  • Stock Information
  • Founded
  • CPIX 1999
  • ADAP 2008
  • Country
  • CPIX United States
  • ADAP United Kingdom
  • Employees
  • CPIX N/A
  • ADAP N/A
  • Industry
  • CPIX Biotechnology: Pharmaceutical Preparations
  • ADAP Biotechnology: Pharmaceutical Preparations
  • Sector
  • CPIX Health Care
  • ADAP Health Care
  • Exchange
  • CPIX Nasdaq
  • ADAP Nasdaq
  • Market Cap
  • CPIX 68.7M
  • ADAP 71.6M
  • IPO Year
  • CPIX 2009
  • ADAP 2015
  • Fundamental
  • Price
  • CPIX $4.76
  • ADAP $0.24
  • Analyst Decision
  • CPIX
  • ADAP Strong Buy
  • Analyst Count
  • CPIX 0
  • ADAP 5
  • Target Price
  • CPIX N/A
  • ADAP $1.83
  • AVG Volume (30 Days)
  • CPIX 43.3K
  • ADAP 2.6M
  • Earning Date
  • CPIX 05-06-2025
  • ADAP 05-14-2025
  • Dividend Yield
  • CPIX N/A
  • ADAP N/A
  • EPS Growth
  • CPIX N/A
  • ADAP N/A
  • EPS
  • CPIX N/A
  • ADAP N/A
  • Revenue
  • CPIX $37,867,945.00
  • ADAP $178,032,000.00
  • Revenue This Year
  • CPIX N/A
  • ADAP N/A
  • Revenue Next Year
  • CPIX N/A
  • ADAP $65.49
  • P/E Ratio
  • CPIX N/A
  • ADAP N/A
  • Revenue Growth
  • CPIX N/A
  • ADAP 195.34
  • 52 Week Low
  • CPIX $1.04
  • ADAP $0.20
  • 52 Week High
  • CPIX $7.25
  • ADAP $1.48
  • Technical
  • Relative Strength Index (RSI)
  • CPIX 56.04
  • ADAP 37.78
  • Support Level
  • CPIX $3.98
  • ADAP $0.23
  • Resistance Level
  • CPIX $4.41
  • ADAP $0.26
  • Average True Range (ATR)
  • CPIX 0.30
  • ADAP 0.04
  • MACD
  • CPIX 0.06
  • ADAP 0.01
  • Stochastic Oscillator
  • CPIX 98.00
  • ADAP 31.85

About CPIX Cumberland Pharmaceuticals Inc.

Cumberland Pharmaceuticals Inc is a specialty pharmaceutical company focused on the acquisition, development, and commercialization of branded prescription pharmaceutical products. The Company has one operating segment which is specialty pharmaceutical products. The company's primary target markets are hospital acute care, gastroenterology, rheumatology, and oncology. The company promotes its approved products through its hospital, field, and oncology sales divisions in the United States and establishes a network of international partners to register and provide medicines to patients in their countries. The company's revenue is derived from the product sales of FDA-approved pharmaceutical brands. Its brands include Acetadote, Caldolor, Kristalose, Omeclamox, Sancuso, Vaprisol and Vibativ.

About ADAP Adaptimmune Therapeutics plc

Adaptimmune Therapeutics PLC is a clinical-stage biopharmaceutical company. It focused on providing novel cell therapies to patients, particularly in solid tumors. It has developed a comprehensive proprietary platform that enables it to identify cancer targets, find and genetically engineer T-cell receptors, and produce TCR therapeutic candidates for administration to patients. Its programs include MAGE-A4 SPEAR T-cell therapy, NY-ESO SPEAR T-cell, CD70 and others for multiple cancer types.

Share on Social Networks: